Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis.

ABSTRACT:

Background

As stereotactic body radiation therapy (SBRT) has shown to be effective and safe in patients with hepatocellular carcinoma (HCC), the aim of our propensity score matched analysis was to evaluate the efficacy of SBRT in comparison to transarterial chemoembolization (TACE) in intermediate and advanced HCC.

Methods

Patients treated with TACE (n = 367) and patients allocated to SBRT (n = 35) were enrolled in this study. Propensity score matching was performed to adjust for differences in baseline and tumor characteristics of TACE and SBRT patients. Local tumor control (LC) 1 year after treatment, overall survival (OS) and 1-year mortality were assessed.

Results

Patients treated with SBRT have received more prior HCC treatments compared to TACE patients. The LC

SUBMITTER: Bettinger D 

PROVIDER: S-EPMC6085616 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature